Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Koushyar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|July 3, 2025
A spotlight on the MSc Cancer at UCL, 15 years onSarah Koushyar, John A Hartley
Cancer Letters|October 10, 2015
Unveiling the potential of prohibitin in cancerSarah Koushyar, Wen G Jiang, D Alwyn Dart
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 13, 2016
The interaction of Wnt-11 and signalling cascades in prostate cancerSarah Koushyar, Guy H Grant, Pinar Uysal-Onganer
International Journal of Molecular Sciences|June 4, 2020
Targeting Wnt Signaling for the Treatment of Gastric CancerSarah Koushyar, Arfon G Powell, Elizabeth Vincan, et al.
Anticancer Research|October 2, 2019
MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and GrowthD Alwyn Dart, Sarah Koushyar, Ben E Lanning, et al.
International Journal of Molecular Sciences|August 14, 2025
From Hypoxia to Bone: Reprogramming the Prostate Cancer Metastatic CascadeMelissa Santos, Sarah Koushyar, Dafydd Alwyn Dart, et al.
Biomolecules|February 25, 2022
Exploring the Wnt Pathway as a Therapeutic Target for Prostate CancerSarah Koushyar, Valerie S Meniel, Toby J Phesse, et al.
International Journal of Molecular Sciences|June 28, 2023
Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer CellsSarah Koushyar, Pinar Uysal-Onganer, Wen Guo Jiang, et al.
Cancer Research|January 10, 2019
<i>Frizzled-7</i> Is Required for Wnt Signaling in Gastric Tumors with and Without <i>Apc</i> MutationsDustin J Flanagan, Nick Barker, Natasha S Di Costanzo, et al.
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|July 3, 2025
A spotlight on the MSc Cancer at UCL, 15 years onSarah Koushyar, John A Hartley
Cancer Letters|October 10, 2015
Unveiling the potential of prohibitin in cancerSarah Koushyar, Wen G Jiang, D Alwyn Dart
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 13, 2016
The interaction of Wnt-11 and signalling cascades in prostate cancerSarah Koushyar, Guy H Grant, Pinar Uysal-Onganer
International Journal of Molecular Sciences|June 4, 2020
Targeting Wnt Signaling for the Treatment of Gastric CancerSarah Koushyar, Arfon G Powell, Elizabeth Vincan, et al.
Anticancer Research|October 2, 2019
MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and GrowthD Alwyn Dart, Sarah Koushyar, Ben E Lanning, et al.
International Journal of Molecular Sciences|August 14, 2025
From Hypoxia to Bone: Reprogramming the Prostate Cancer Metastatic CascadeMelissa Santos, Sarah Koushyar, Dafydd Alwyn Dart, et al.
Biomolecules|February 25, 2022
Exploring the Wnt Pathway as a Therapeutic Target for Prostate CancerSarah Koushyar, Valerie S Meniel, Toby J Phesse, et al.
International Journal of Molecular Sciences|June 28, 2023
Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer CellsSarah Koushyar, Pinar Uysal-Onganer, Wen Guo Jiang, et al.
Cancer Research|January 10, 2019
<i>Frizzled-7</i> Is Required for Wnt Signaling in Gastric Tumors with and Without <i>Apc</i> MutationsDustin J Flanagan, Nick Barker, Natasha S Di Costanzo, et al.
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
Pageof 2